The NCI Community Oncology Research Program (NCORP) is a national network of cancer care investigators, providers, academia, and other organizations that care for diverse populations in health systems.
The DCP Community Oncology and Prevention Trials Research Group administers this program.
On this page
About NCORP
The program brings cancer clinical trials and control and delivery studies to individuals in their own communities, thereby generating a broadly applicable evidence base that contributes to improved patient outcomes and a reduction in cancer disparities.
Grantee Details
No matching Grants were found.
Clinical Trials
| Title Sort descending | Intervention | Sponsor | Status |
|---|---|---|---|
| Developing an Internet-Delivered Sexual Health Program for Breast Cancer Survivors, SHINE Trial | Internet-based Intervention | Wake Forest University Health Sciences | Recruiting |
| Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance | dietary education and counseling, prostate cancer foundation booklet | Alliance for Clinical Trials in Oncology | Completed |
| Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer | Digital Mammography, Digital Tomosynthesis Mammography, Laboratory Biomarker Analysis | ECOG-ACRIN Cancer Research Group | Recruiting |
| Does the Use of a Genomic Tumor Board Increase the Number of Patients Who Receive Genome-Informed Treatment | Best Practice, Chart Abstraction, Educational Intervention, Genomic Profile, Interview, Questionnaire Administration, Tumor Board Review | SWOG Cancer Research Network | Recruiting |
| Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy | DLA (diphenhydramine, lidocaine and antacids) rinse, Placebo, doxepin hydrochloride oral solution | Alliance for Clinical Trials in Oncology | Completed |
| Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer | Duloxetine, Duloxetine Hydrochloride, Oxaliplatin, Placebo, Quality-of-Life Assessment, Questionnaire Administration | Alliance for Clinical Trials in Oncology | Active, not recruiting |
| Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers | Early palliative care | Alliance for Clinical Trials in Oncology | Completed |
| Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection | Physical therapy, educational intervention, quality of life assessment | Alliance for Clinical Trials in Oncology | Completed |
| Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer | Interview, Questionnaire Administration | Wake Forest University Health Sciences | Active, not recruiting |
| Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment | Assessment of Therapy Complications, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Questionnaire Administration | Children's Oncology Group | Recruiting |